Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
Authors
Keywords
Melatonin, Vemurafenib, NF-κB, iNOS, hTERT, Cancer stem cell
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-04
DOI
10.1186/s13046-019-1036-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells
- (2018) Hyemin Lee et al. JOURNAL OF PINEAL RESEARCH
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
- (2017) Xian Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma
- (2017) Brittani Seynnaeve et al. Scientific Reports
- Metastatic melanoma: Pathologic characterization, current treatment, and complications of therapy
- (2016) Mark R. Wick et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Immunotherapy of melanoma: Present options and future promises
- (2015) Anand Rotte et al. CANCER AND METASTASIS REVIEWS
- High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells
- (2015) Maria Ausiliatrice Puglisi et al. JOURNAL OF PATHOLOGY
- The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration
- (2015) M. Meyer et al. NEUROSCIENCE
- Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
- (2015) Ryan B. Corcoran et al. Oncotarget
- Melatonin Sensitizes H1975 Non-Small-Cell Lung Cancer Cells Harboring a T790M-Targeted Epidermal Growth Factor Receptor Mutation to the Tyrosine Kinase Inhibitor Gefitinib
- (2014) Miyong Yun et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Melatonin: functions and ligands
- (2014) Mahaveer Singh et al. DRUG DISCOVERY TODAY
- Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells
- (2014) Han Sung Kim et al. PLoS One
- High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
- (2014) Loredana Alberti et al. PLoS One
- Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma
- (2013) Ao-Xue Wang et al. IUBMB LIFE
- Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells
- (2012) Virginia Alvarez-García et al. JOURNAL OF PINEAL RESEARCH
- Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways
- (2012) Jingshu Wang et al. JOURNAL OF PINEAL RESEARCH
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- (2012) Radomir M. Slominski et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
- (2012) J. G. Greger et al. MOLECULAR CANCER THERAPEUTICS
- A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
- (2012) J. E. Till et al. RADIATION RESEARCH
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
- (2011) H. Yang et al. CANCER RESEARCH
- Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth
- (2011) G. Civenni et al. CANCER RESEARCH
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MDR1 expression identifies human melanoma stem cells
- (2008) Gilmor I. Keshet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NF-κB Mediates Mitogen-Activated Protein Kinase Pathway-Dependent iNOS Expression in Human Melanoma
- (2008) Deon G. Uffort et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now